cdmo.directory
← Compare landing

Gland Pharma Limited vs OMISAN S.p.A.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/gland-pharma/omisan

CategoryGland Pharma LimitedOMISAN S.p.A.
Listed sitecdmocdmo
SummaryGland Pharma is a vertically integrated CDMO offering sterile injectable manufacturing across vials, lyophilized, prefilled syringes, and ophthalmic formats, with four cGMP-compliant formulation facilities and four API manufacturing units, supported by R&D capabilities in formulation, analytical, and process development.Italian maker of sterile ophthalmic medical devices, including eye drops, sprays, eyewashes, and contact lens solutions. Offers private label and CDMO manufacturing for ophthalmic multinationals, with preservative-free dispensing technologies.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Prefilled Syringe (PFS) Filling
  • Ophthalmic Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Ophthalmic Manufacturing
Modalities
  • Small Molecule
  • Biologics (Other)
Data not yet provided.
IndicationsData not yet provided.
  • Ophthalmology
Locations
  • Headquarters / Dundigal Formulation Facility, Hyderabad, Telangana, India
  • Pashamylaram Formulation Facility, Hyderabad, Telangana, India
  • Penems Formulation Facility, Hyderabad, Telangana, India
  • R&D Pilot Plant, Dundigal, Hyderabad, Telangana, India
  • Biotech Drug Substance Facility, Genome Valley, Hyderabad, Telangana, India
  • API Manufacturing Facility 1, Visakhapatnam, Andhra Pradesh, India
  • API Manufacturing Facility 2, Visakhapatnam, Andhra Pradesh, India
  • Oncology Facility, Visakhapatnam, Andhra Pradesh, India
  • Headquarters, Guidonia Montecelio, RM, Italy
Certifications
  • FDA · Identifier: USFDA
  • MHRA · Identifier: MHRA
  • EMA · Identifier: EMA
  • ANVISA · Identifier: ANVISA
  • TGA · Identifier: TGA
  • BGV Hamburg · Identifier: BGV
  • WHO · Identifier: WHO
  • Health Canada · Identifier: Health Canada
  • MCC · Identifier: MCC
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.